Discover 1,621 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,621
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
for
RSV Infection
Location: Durham NC, North Chesterfield VA, Richmond VA,
Sponsor: Pfizer
Sex: All
Age: 0+
Code: NCT06866405
Phase3, Recruiting
Telerehabilitation In The Home After Stroke
for
Stroke
Location: Durham NC, Chapel Hill NC, Washington D.C. DC,
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 70+
Code: NCT06682429
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
for
COVID-19 Infection
Location: Durham NC, Washington D.C. DC, Charleston SC,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07013474
Phase3, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Durham NC, Chapel Hill NC, Charlotte NC, Richmond VA,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
Hyperbaric Oxygen Brain Injury Treatment Trial
for
Traumatic Brain Injury
Location: Durham NC, Baltimore MD, Lexington KY, Detroit MI,
Sponsor: Gaylan Rockswold
Sex: All
Age: 16 - 65
Code: NCT02407028
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Pharmacogenomic Exploration of Lacosamide Response
for
Epilepsy
Location: Durham NC
Sponsor: Royal College of Surgeons, Ireland
Sex: All
Age: 18 - 65
Code: NCT01399528
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Durham NC, Charlotte NC, Richmond VA, Pittsburgh PA,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase2, Recruiting
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer